Potassium citrate, a proven Earth-based therapy to minimize calcium-containing renal stone development, is being tested in a double-blind study as a countermeasure to reduce the risk of renal stone formation in crewmembers on the International Space Station. Subjects ingest two potassium citrate or placebo pills with the last meal of the day from L-3 (days prior launch) to R+14 (days after landing). Food, fluid, exercise, and medications are monitored for 48 hours (24 hours prior to and during the 24-hour urine collection period) to assess environmental influences other than microgravity.


    Zugriff

    Zugriff prüfen

    Verfügbarkeit in meiner Bibliothek prüfen

    Bestellung bei Subito €


    Exportieren, teilen und zitieren



    Titel :

    Renal stone risk during spaceflight: assessment and countermeasure validation


    Beteiligte:
    Whitson, P. (Autor:in) / Bergh, K. (Autor:in) / Maender, C. (Autor:in) / Pietrzyk, R. (Autor:in) / Jones, J. (Autor:in) / Sams, C. (Autor:in)


    Erscheinungsdatum :

    01.01.2004


    Format / Umfang :

    502821 byte





    Medientyp :

    Aufsatz (Konferenz)


    Format :

    Elektronische Ressource


    Sprache :

    Englisch



    Renal Stone Risk During Spaceflight: Assessment and Countermeasure Validation

    Pietrzyk, Robert A. / Whitson, Peggy A. / Sams, Clarence F. et al. | NTRS | 2009



    Renal stone assessment during spaceflight - Assessment and countermeausure validation

    Whitson, Peggy / Pietrzyk, Robert / Jones, Jeffrey et al. | AIAA | 2001


    AIAA-2001-4901 Renal Stone Risk During Space Flight: Assessment and Countermeasure Validation

    Whitson, P. / Pietrzyk, R. / Jones, J. et al. | British Library Conference Proceedings | 2001